MX369625B - Composiciones para solubilizar celulas y/o tejido. - Google Patents

Composiciones para solubilizar celulas y/o tejido.

Info

Publication number
MX369625B
MX369625B MX2014013794A MX2014013794A MX369625B MX 369625 B MX369625 B MX 369625B MX 2014013794 A MX2014013794 A MX 2014013794A MX 2014013794 A MX2014013794 A MX 2014013794A MX 369625 B MX369625 B MX 369625B
Authority
MX
Mexico
Prior art keywords
compositions
tissue
solubilizing
solubilizing cells
skin
Prior art date
Application number
MX2014013794A
Other languages
English (en)
Other versions
MX2014013794A (es
Inventor
Hee Hwang Byeong
Mitragotri Samir
M Lebovitz Russell
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MX2014013794A publication Critical patent/MX2014013794A/es
Publication of MX369625B publication Critical patent/MX369625B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5422—Polymers characterized by specific structures/properties characterized by the charge nonionic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5428—Polymers characterized by specific structures/properties characterized by the charge amphoteric or zwitterionic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a composiciones solubilizantes. Las composiciones comprenden al menos un surfactante zwitteriónico y al menos un surfactante no iónico. En una modalidad, las composiciones pueden ser útiles para solubilizar y remodelar y/o extirpar tejido sobre o debajo de la piel de un paciente, de manera opcional junto con la aplicación de energía a un área de interés en la piel. En una modalidad, al menos un aflauto se puede recoger y analizar del tejido solubilizado.
MX2014013794A 2012-05-16 2012-05-16 Composiciones para solubilizar celulas y/o tejido. MX369625B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/038169 WO2013172832A1 (en) 2012-05-16 2012-05-16 Compositions for solubilizing cells and/or tissue

Publications (2)

Publication Number Publication Date
MX2014013794A MX2014013794A (es) 2015-04-08
MX369625B true MX369625B (es) 2019-11-14

Family

ID=49584087

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013794A MX369625B (es) 2012-05-16 2012-05-16 Composiciones para solubilizar celulas y/o tejido.

Country Status (10)

Country Link
EP (2) EP3056559B1 (es)
JP (1) JP2015528691A (es)
KR (1) KR102099487B1 (es)
CN (1) CN104520418A (es)
AU (2) AU2012380348B2 (es)
BR (1) BR112014028239B1 (es)
CA (1) CA2873707A1 (es)
IN (1) IN2014MN02536A (es)
MX (1) MX369625B (es)
WO (1) WO2013172832A1 (es)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5358492A (en) * 1976-11-08 1978-05-26 Kao Corp Anti-foggig agent composition with lng lasting effect
US5639630A (en) * 1995-05-16 1997-06-17 Bayer Corporation Method and reagent composition for performing leukocyte differential counts on fresh and aged whole blood samples, based on intrinsic peroxidase activity of leukocytes
CA2264687C (en) * 1996-10-24 2006-04-25 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
ES2286852T3 (es) * 1997-08-04 2007-12-01 Advanced Life Science Institute, Inc. Metodos para detectar o analizar virus.
US6589173B1 (en) 2000-07-17 2003-07-08 The Regents Of The University Of California Ultrasound system for disease detection and patient treatment
FR2848848B1 (fr) * 2002-12-19 2005-01-28 Oreal Composition de lavage des matieres keratiniques a base de tensioactif amphotere et de peg modifie par un groupe hydrophobe
US7186522B2 (en) * 2003-03-31 2007-03-06 Cytyc Corporation Papanicolau staining process
WO2005012549A2 (en) * 2003-08-01 2005-02-10 Fqubed, Inc. Apparatus and methods for evaluating the barrier properties of a membrane
CN1901935A (zh) * 2003-12-30 2007-01-24 惠氏公司 具有改进耐受性的免疫原组合物中的疏水性蛋白调配物
JP4422550B2 (ja) * 2004-05-25 2010-02-24 日華化学株式会社 親水性フッ素樹脂粒子の製造方法
WO2006026248A1 (en) * 2004-08-25 2006-03-09 Sigma-Aldrich Co. Compositions and methods employing zwitterionic detergent combinations
US8389582B2 (en) * 2007-08-06 2013-03-05 Samir Mitragotri Composition for solubilizing tissue comprising 3-(decyl dimethyl ammonio) propane sulfonate and tetraethylene glycol dodecyl ether
WO2009048681A2 (en) * 2007-08-06 2009-04-16 The Regents Of The University Of California Methods of tissue-based diagnosis
EP2278997B1 (en) * 2008-04-21 2016-08-10 Nanobio Corporation Nanoemulsion influenza vaccine
EP2293787A1 (en) * 2008-04-25 2011-03-16 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections
US7700530B2 (en) * 2008-06-30 2010-04-20 Kimberly Clark Worldwide, Inc. Polysensorial personal care cleanser comprising a quaternary silicone surfactant
JP5382687B2 (ja) * 2008-11-12 2014-01-08 独立行政法人産業技術総合研究所 ルシフェリン−ルシフェラーゼ反応における発光強度の低下を抑制するための組成物及び方法
WO2010087964A2 (en) * 2009-01-28 2010-08-05 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
EP3073263B1 (en) * 2009-02-13 2020-04-29 The Regents of the University of California Device, composition and method for tissue-based diagnosis
US20120064136A1 (en) * 2010-09-10 2012-03-15 Nanobio Corporation Anti-aging and wrinkle treatment methods using nanoemulsion compositions

Also Published As

Publication number Publication date
EP3056559A3 (en) 2016-10-12
AU2012380348A1 (en) 2015-01-22
KR20150023394A (ko) 2015-03-05
EP2756061A1 (en) 2014-07-23
EP3056559B1 (en) 2019-07-10
WO2013172832A1 (en) 2013-11-21
AU2017203389A1 (en) 2017-06-08
IN2014MN02536A (es) 2015-09-04
EP3056559A2 (en) 2016-08-17
BR112014028239A2 (pt) 2017-06-27
BR112014028239B1 (pt) 2021-05-11
KR102099487B1 (ko) 2020-04-09
CA2873707A1 (en) 2013-11-21
AU2012380348B2 (en) 2017-02-23
EP2756061A4 (en) 2014-08-13
MX2014013794A (es) 2015-04-08
CN104520418A (zh) 2015-04-15
JP2015528691A (ja) 2015-10-01

Similar Documents

Publication Publication Date Title
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
WO2012116081A3 (en) Methods for identifying cosmetic agents for skin care compositions
WO2013078402A3 (en) Tissue and stone removal device
USD695418S1 (en) Electrophoresis apparatus
CA2865011C (en) Methods and compositions for treating huntington's disease
FR2961087B1 (fr) Outil de prelevement d'un echantillon de tissu animal.
WO2013063418A3 (en) Devices and methods for performing knee arthroplasty
MX379016B (es) Composiciones y metodos para tratar enfermedad de gaucher.
Baum From Norm to Eric: avoiding lifestyle drift in Australian health policy.
MX346717B (es) Dispositivos de recogida de sangre que contienen un agente estabilizador de sangre.
WO2013166478A3 (en) Surgical instruments for oct assisted procedures
GB201304564D0 (en) Novel removable clothing
IL219318A0 (en) Pterostilbene (pter) for use in the prevention and/or treatment of skin diseases, damages or injures
EP2511948A4 (en) DRYING AGENT AND DRYING PROCESS WITH THIS
EP3453723A3 (en) Anti-asic1 antibodies and uses thereof
MX357227B (es) Nanoparticulas basadas en lipidos.
WO2014124307A3 (en) Targeted theranostics
MX2015017095A (es) Composiciones y metodos para tratamiento de la piel.
MX2015003074A (es) Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas.
HK1215391A1 (zh) 使用胎盘细胞外基质治疗口腔病变
EP3057535A4 (en) Bone grafts including osteogenic stem cells, and methods relating to the same
FR2982588B1 (fr) Panneau composite a ecope de prelevement integree
WO2012045974A3 (fr) Utilisation cosmétique d'un extrait de tropaeolum majus comme principe actif pour favoriser l'oxygénation du tissu cutané
WO2014169011A3 (en) Methods for treating immune diseases
MX369625B (es) Composiciones para solubilizar celulas y/o tejido.

Legal Events

Date Code Title Description
FG Grant or registration